Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥107.21 Million ≈ $15.69 Million USD) by net assets (CN¥3.13 Billion ≈ $458.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Haoyuan Chemexpress Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Haoyuan Chemexpress Co. Ltd. A debt and liabilities for a breakdown of total debt and financial obligations.

Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Pandox AB (publ)
ST:PNDX-B
0.052x
Ambu A/S
CO:AMBU-B
0.018x
EIH Limited
NSE:EIHOTEL
0.054x
Hefei Meiya Optoelectronic Technology Inc
SHE:002690
0.087x
Luenmei Quantum Co Ltd
SHG:600167
0.009x
BB Biotech AG
SW:BION
-0.033x
Zhongrun Resources Investment
SHE:000506
0.089x
BW LPG Limited
F:BW9
0.094x

Annual Cash Flow Conversion Efficiency for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Haoyuan Chemexpress Co. Ltd. A.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.90 Billion
≈ $424.98 Million
CN¥381.96 Million
≈ $55.89 Million
0.132x +633.61%
2023-12-31 CN¥2.53 Billion
≈ $369.67 Million
CN¥-62.27 Million
≈ $-9.11 Million
-0.025x +76.07%
2022-12-31 CN¥2.33 Billion
≈ $341.24 Million
CN¥-240.23 Million
≈ $-35.15 Million
-0.103x -427.11%
2021-12-31 CN¥1.84 Billion
≈ $268.73 Million
CN¥57.83 Million
≈ $8.46 Million
0.031x -85.77%
2020-12-31 CN¥527.81 Million
≈ $77.24 Million
CN¥116.79 Million
≈ $17.09 Million
0.221x +54.98%
2019-12-31 CN¥399.73 Million
≈ $58.49 Million
CN¥57.07 Million
≈ $8.35 Million
0.143x -10.78%
2018-12-31 CN¥177.65 Million
≈ $26.00 Million
CN¥28.43 Million
≈ $4.16 Million
0.160x +72.73%
2017-12-31 CN¥114.74 Million
≈ $16.79 Million
CN¥10.63 Million
≈ $1.56 Million
0.093x +143.20%
2016-12-31 CN¥56.86 Million
≈ $8.32 Million
CN¥-12.19 Million
≈ $-1.78 Million
-0.214x -484.77%
2015-12-31 CN¥32.65 Million
≈ $4.78 Million
CN¥1.82 Million
≈ $266.30K
0.056x +146.55%
2014-12-31 CN¥33.10 Million
≈ $4.84 Million
CN¥-3.96 Million
≈ $-579.94K
-0.120x -197.57%
2013-12-31 CN¥9.70 Million
≈ $1.42 Million
CN¥1.19 Million
≈ $174.12K
0.123x --

About Shanghai Haoyuan Chemexpress Co. Ltd. A

SHG:688131 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.25 Billion
CN¥15.39 Billion CNY
Market Cap Rank
#5890 Global
#1259 in China
Share Price
CN¥72.56
Change (1 day)
-2.68%
52-Week Range
CN¥36.75 - CN¥88.38
All Time High
CN¥148.50
About

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.